It was removed from the FDA's Category 2 restricted list on April 22, 2026, but that alone doesn't authorize compounding pharmacies to prepare it for human use
Triny rarely recommends this one
It can reduce the risk of cardiovascular issues like heart disease and strokes in humans
Both PAD and tTG are active in joints and the intestine, with the latter of these modification proteins being over expressed in the synovium of RA patients suggesting a possible role in disease pathogenesis (Lauzier et al
Available to buy in the UK from Peptides Lab UK, 5-Amino-1MQ is one of the most extensively characterised selective NNMT inhibitors in current metabolic research, with published pre-clinical evidence spanning adipocyte biology, diet-induced obesity models, NAD+/SAM pathway studies, skeletal muscle function research, and cancer cell biology